MARKET

SSKN

SSKN

STRATA Skin
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9429
+0.0419
+4.65%
Closed 16:00 03/30 EDT
OPEN
0.9010
PREV CLOSE
0.9010
HIGH
1.000
LOW
0.9010
VOLUME
11.43K
TURNOVER
--
52 WEEK HIGH
2.990
52 WEEK LOW
0.7520
MARKET CAP
31.79M
P/E (TTM)
-7.8772
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SSKN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SSKN stock price target is 5.63 with a high estimate of 6.00 and a low estimate of 5.25.

EPS

SSKN News

More
  • Edited Transcript of SSKN earnings conference call or presentation 17-Mar-20 12:30pm GMT
  • Thomson Reuters StreetEvents · 03/18 00:21
  • STRATA Skin Sciences, Inc. (SSKN) Dolev Rafaeli on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/17 17:20
  • HC Wainwright & Co. Downgrades Strata Skin Sciences to Neutral
  • Benzinga · 03/17 16:00
  • The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
  • Benzinga · 03/17 15:38

Industry

Advanced Medical Equipment & Technology
+3.53%
Healthcare Equipment & Supplies
+3.82%

Hot Stocks

Symbol
Price
%Change

About SSKN

STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company's technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.
More

Webull offers kinds of STRATA Skin Sciences Inc stock information, including NASDAQ:SSKN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SSKN stock news, and many more online research tools to help you make informed decisions.